132 related articles for article (PubMed ID: 30173479)
1. [NEW ERA OF PERSONALIZED MEDICINE THROUGH NEXT－GENERATION SEQUENCING].
Furukawa Y
Nihon Geka Gakkai Zasshi; 2016 Nov; 117(6):530-5. PubMed ID: 30173479
[No Abstract] [Full Text] [Related]
2. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
Blumenthal GM; Mansfield E; Pazdur R
JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
[No Abstract] [Full Text] [Related]
3. Personalized cancer genomics: the road map to clinical implementation.
Yousef GM
Clin Chem; 2012 Apr; 58(4):661-3. PubMed ID: 22322979
[No Abstract] [Full Text] [Related]
4. [Personalized targeted therapy for lung cancer].
Wu K; House L; Liu W; Cho WC
Zhongguo Fei Ai Za Zhi; 2013 Aug; 16(8):C21-34. PubMed ID: 23945250
[TBL] [Abstract][Full Text] [Related]
5. Implementing Genome-Driven Oncology.
Hyman DM; Taylor BS; Baselga J
Cell; 2017 Feb; 168(4):584-599. PubMed ID: 28187282
[TBL] [Abstract][Full Text] [Related]
6. Cancer genomics guide clinical practice in personalized medicine.
Lehmann-Che J; Poirot B; Boyer JC; Evrard A
Therapie; 2017 Sep; 72(4):439-451. PubMed ID: 28258721
[TBL] [Abstract][Full Text] [Related]
7. Pitfalls of Personalizing Cancer Treatment.
Perez K
Am J Clin Oncol; 2016 Feb; 39(1):107. PubMed ID: 26785382
[No Abstract] [Full Text] [Related]
8. Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.
Subbiah V; Wagner MJ; McGuire MF; Sarwari NM; Devarajan E; Lewis VO; Westin S; Kato S; Brown RE; Anderson P
Oncotarget; 2015 Dec; 6(38):40642-54. PubMed ID: 26510912
[TBL] [Abstract][Full Text] [Related]
9. Widespread Genomic Testing Deemed Feasible.
Cancer Discov; 2017 Aug; 7(8):786-787. PubMed ID: 28642250
[TBL] [Abstract][Full Text] [Related]
10. [PREFACE TO “NEW ERA OF PERSONALIZED MEDICINE THROUGH NEXT-GENERATION SEQUENCING”].
Obama K
Nihon Geka Gakkai Zasshi; 2016 Nov; 117(6):529. PubMed ID: 30173478
[No Abstract] [Full Text] [Related]
11. Personalized cancer vaccines: Targeting the cancer mutanome.
Zhang X; Sharma PK; Peter Goedegebuure S; Gillanders WE
Vaccine; 2017 Feb; 35(7):1094-1100. PubMed ID: 27449681
[TBL] [Abstract][Full Text] [Related]
12. Should next-generation sequencing tests be performed on all cancer patients?
McKenzie AJ; H Dilks H; Jones SF; Burris H
Expert Rev Mol Diagn; 2019 Feb; 19(2):89-93. PubMed ID: 30618301
[No Abstract] [Full Text] [Related]
13. Group mentality: Determining if targeted treatments really work for cancer.
Chakradhar S
Nat Med; 2016 Mar; 22(3):222-4. PubMed ID: 26937611
[No Abstract] [Full Text] [Related]
14. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
Albin N; Mc Leer A; Sakhri L
Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
[TBL] [Abstract][Full Text] [Related]
15. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
Syn NL; Yong WP; Goh BC; Lee SC
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
[TBL] [Abstract][Full Text] [Related]
16. Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials.
Le Tourneau C; Kamal M; Tsimberidou AM; Bedard P; Pierron G; Callens C; Rouleau E; Vincent-Salomon A; Servant N; Alt M; Rouzier R; Paoletti X; Delattre O; Bièche I
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26598514
[TBL] [Abstract][Full Text] [Related]
17. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
[No Abstract] [Full Text] [Related]
18. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy.
Wu D; Wang DC; Cheng Y; Qian M; Zhang M; Shen Q; Wang X
Semin Cancer Biol; 2017 Feb; 42():13-19. PubMed ID: 27840278
[TBL] [Abstract][Full Text] [Related]
19. Ushering in the Era of Precision Medicine.
Oncology (Williston Park); 2020 Aug; 34(8):314-316. PubMed ID: 32785927
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial drug therapy for cancer in the post-genomic era.
Al-Lazikani B; Banerji U; Workman P
Nat Biotechnol; 2012 Jul; 30(7):679-92. PubMed ID: 22781697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
